Abstract
The epidermal growth factor receptor (EGFR) is one of the most appropriate target molecules for cancer therapy because of its high expression in epithelial cancers. A novel EGFR-tyrosine-kinase inhibitor, ZD1839, has been approved as a drug for non-small cell lung cancer (NSCLC), and many other agents are now being tested in clinical trials. Cytotoxic T lymphocyte (CTL)-directed epitope peptides could be another class of useful compounds in EGFR-targeted therapies. However, at present, there are no data on CTL-directed peptides of EGFR. Therefore, this study aimed to identify immunogenic EGFR-derived peptides in HLA-A24(+) NSCLC patients. We report in this study three such EGFR-derived peptides at positions 54-62, 124-132 and 800-809. These peptides were recognised by both cellular and humoral immune responses in most of the peripheral blood mononuclear cells (PBMCs) and sera from NSCLC patients that we tested. These results may provide a scientific basis for the development of EGFR-based immunotherapy.
References
Dec 6, 1985·Science·L CoussensU Francke
Jan 16, 1986·Nature·T YamamotoK Toyoshima
Jun 1, 1995·The Journal of Experimental Medicine·B FiskC G Ioannides
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·G E PeoplesT J Eberlein
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·E JägerA Knuth
Feb 13, 2001·Archives of Oral Biology·M H ParkarI Olsen
May 16, 2002·Cancer Immunology, Immunotherapy : CII·Naoya HidaKyogo Itoh
Jul 24, 2002·Tissue Antigens·S OhkouchiK Itoh
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
May 20, 2003·Tissue Antigens·N KawamotoK Itoh
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vincent A MillerJudith Ochs
Jun 26, 2003·Cancer Science·Takashi MineHideaki Yamana
Jul 30, 2003·The Prostate·Masanori NoguchiShinshi Noda
Sep 12, 2003·Cancer Science·Yuji SatoSatoru Todo
Feb 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takashi MineHideaki Yamana
Citations
Dec 1, 2012·Cancer Immunology, Immunotherapy : CII·Masanori NoguchiKyogo Itoh
Jun 19, 2007·Medical Microbiology and Immunology·Yukari TakaoMichio Sata
Apr 16, 2013·Developmental and Comparative Immunology·Satoko MatsuedaTetsuro Sasada
Jun 30, 2007·Cancer Biotherapy & Radiopharmaceuticals·Joanne M Wroblewski, John R Yannelli
Dec 23, 2014·International Journal of Oncology·Kazuya OfujiTetsuya Nakatsura
Nov 12, 2016·Frontiers in Pharmacology·Tetsuro SasadaYuki Fujimoto
Dec 15, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mizuhiko TerasakiKyogo Itoh
Oct 3, 2006·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·M M AloysiusO Eremin
Jan 1, 2012·Cancers·Andrea KiesslingMarc Schmitz
Jul 27, 2005·Stem Cells·Hiroko TakedatsuKyogo Itoh
May 16, 2009·Cancer Science·Yoshihiko HirohashiNoriyuki Sato
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Naoki YajimaRyuichi Tanaka
Feb 23, 2021·Cancer Science·Shunsuke KondoNoboru Yamamoto
Oct 16, 2020·Scientific Reports·Yuki TanakaTeruhiro Utsugi